Riskpilot← Back to searchSign inGet full accessMEDI 3 AS
ASActiveOrg 941455077Kongens Gate 11, 6002 ÅlesundOther human health activities n.e.c. · NACE 8699Est. 198663 employeeswww.medi3.no
Revenue 2024
NOK 213,1M
+4% vs 2023
EBITDA margin
8.5%
-22% vs 2023
Equity ratio
50.8%
Financial strength
Net profit 2024
NOK 13,9M
+201% vs 2023
| Revenue | NOK 213,1M | +4% |
| EBITDA | NOK 18,1M | -22% |
| Net profit | NOK 13,9M | +201% |
| Total assets | NOK 97M | +22% |
| Equity | NOK 49,3M | +39% |
| Employees | 63 | — |
Legal name
MEDI 3 AS
Org number
941455077
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
5. desember 1986
Share capital
NOK 23 260 320
Employees
63 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Tilby helsetjenester til privatpersoner og bedrifter.
Address
Kongens Gate 11, 6002 Ålesund
Phone
+4770117000
Website
www.medi3.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 119 870 | 121 865 | 135 856 | 120 579 | 23 340 | 24 157 | 159 114 | 160 470 | 158 901 | 138 528 | 138 623 | 141 707 | 164 631 | 160 431 | 204 142 | 213 077 |
| Staff expenses | −37 928 | −39 172 | −47 404 | −29 096 | −6 651 | −7 585 | −56 964 | −58 706 | −56 886 | −51 524 | −46 553 | −45 431 | −53 029 | −52 294 | −68 220 | −71 235 |
| EBITDA | 15 764 | 14 560 | 11 810 | 43 051 | 1 553 | 1 149 | 14 070 | 13 247 | 10 017 | 6 163 | 6 790 | 10 656 | 21 684 | 15 068 | 23 097 | 18 070 |
| Depreciation & amort. | −7 227 | −8 060 | −6 794 | −3 204 | −1 433 | −1 352 | −5 507 | −4 593 | −4 345 | −5 870 | −0 | −0 | −2 132 | −1 761 | −2 014 | −2 185 |
| EBIT | 8 537 | 6 500 | 5 016 | 39 846 | 120 | −203 | 8 563 | 8 653 | 5 672 | 293 | 6 790 | 10 656 | 19 552 | 13 308 | 21 083 | 15 885 |
| Net financials | −1 443 | −178 | 325 | −7 284 | 477 | −619 | 27 | −476 | 80 | 1 276 | −85 | 828 | −15 118 | −5 699 | −11 640 | 1 934 |
| Profit before tax | 7 095 | 6 322 | 5 341 | 32 562 | 597 | −821 | 8 590 | 8 177 | 5 753 | 1 569 | 6 705 | 11 484 | 4 434 | 7 609 | 9 442 | 17 819 |
| Tax | 2 128 | 1 863 | 1 540 | 9 166 | 2 060 | 1 716 | 2 498 | 2 286 | 1 454 | 92 | 1 678 | 2 535 | 4 290 | 2 967 | 4 838 | 3 948 |
| Net profit | 4 967 | 4 460 | 3 800 | 23 396 | −1 462 | −2 537 | 6 092 | 5 891 | 4 299 | 1 477 | 5 027 | 8 948 | 144 | 4 642 | 4 604 | 13 871 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 53 865 | 49 284 | 61 095 | 71 632 | 84 118 | 90 751 | 60 387 | 65 660 | 85 991 | 88 790 | 65 966 | 86 700 | 73 797 | 75 014 | 79 384 | 97 042 |
| Equity | 25 008 | 29 468 | 33 268 | 51 207 | 49 744 | 46 618 | 31 706 | 37 598 | 36 987 | 38 464 | 43 491 | 31 033 | 26 176 | 30 818 | 35 423 | 49 294 |
| Long-term debt | −1 871 | −1 710 | 7 513 | 11 467 | 11 242 | 10 398 | 6 158 | 5 667 | 5 063 | 13 655 | 4 313 | 3 938 | 14 625 | 13 125 | 11 625 | 10 125 |
| Short-term debt | 15 214 | 15 987 | 18 475 | 7 289 | 21 276 | 32 921 | 20 605 | 19 677 | 40 761 | 33 373 | 14 934 | 48 277 | 29 925 | 28 296 | 31 343 | 35 931 |
| Total debt | 26 986 | 18 106 | 25 987 | 18 756 | 32 518 | 43 319 | 26 763 | 25 343 | 45 823 | 47 028 | 19 246 | 52 215 | 44 550 | 41 421 | 42 968 | 46 056 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20092024
Equity ratio
50.8%
This company
38.2%
Market median
+33% vs market
20092024
Return on equity
28.1%
This company
18.4%
Market median
+53% vs market
20092024
Net profit margin
6.5%
This company
8.1%
Market median
-20% vs market
20092024
Asset turnover
2.20×
This company
1.12×
Market median
+96% vs market
20092024
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JT Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kaston As | Company | 92.7% | 92.7% | 2024 |
Jangaard Export As | Company | 7.3% | 7.3% | 2022 |
Brødrene Jangaard As | Company | 7.3% | 7.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Aalesund Enterprises As
MEDI 3 AS Board members of MEDI 3 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Terje Teige | Chief Executive Officer | 0 companies |
| Ingvild Skodje Grødal | Board of Directors | 0 companies |
| Sigurd Strand Teige | Chairman | 0 companies |
| Gunnar Haagensen | Board of Directors | 0 companies |
| Ida Caroline Aasland Rotevatn | Board of Directors | 0 companies |
| Tone Kibsgård | Board of Directors | 0 companies |
| Frede Klinkby Uldbæk | Board of Directors | 0 companies |
| Monica Therese Utvik Myklebust | Board of Directors | 0 companies |